Justice Department Joins Lawsuit Alleging Massive Medicare Fraud By UnitedHealth
The Department of Justice is joining a whistleblower lawsuit in a fraud case against UnitedHealth in which damages could top $1 billion.
Health Industry
2,501 - 2,520 of 3,880 Results
-
-
Repeal & Replace Watch
Insurers May Notch Bigger Profits From Fewer Customers In 鈥楾rumpcare鈥
As Congress and the White House try to strike a bargain on an Obamacare repeal plan, the insurance industry likes what it鈥檚 seeing.
-
Repeal & Replace Watch
Popular Guarantee For Young Adults鈥 Coverage May Be Health Law鈥檚 Achilles’ Heel
Republicans and Democrats don鈥檛 agree on much these days, but both parties want to keep the health law鈥檚 provision to allow adults to stay on their parents鈥 plan until age 26. But that could be hurting the marketplace鈥檚 insurance pools.
-
GAO To Launch Investigation Of FDA鈥檚 Orphan Drug Program
The Government Accountability Office said it will investigate potential abuses of the orphan drug program, which offers incentives to drugmakers to develop medicines for rare diseases.
-
Repeal & Replace Watch
House Republicans Recycle Controversial 2003 Bill To Boost Small-Business Insurance
The legislation, passed by the House, would allow nationwide 鈥渁ssociation health plans.鈥 But consumer advocates have raised serious concerns about such options in the past.
-
Repeal & Replace Watch
In Deep-Red Western N.C., Revered Congressman Leads Charge Against GOP Bill
Is Republican Rep. Mark Meadows the man who would kill "Trumpcare"? He enjoys strong support in his gerrymandered western North Carolina district as he leads conservative opposition to the GOP鈥檚 plan for repealing and replacing Obamacare.
-
Repeal & Replace Watch
GOP Bill’s Unheralded Changes In Rules Could Undermine Health Of Neediest
Lesser-known provisions in the Republican proposal to replace the Affordable Care Act would push some Medicaid enrollees out of coverage and cause financial pain for others.
By Emily Bazar -
Prescription Drug Costs Are On The Rise; So Are The TV Ads Promoting Them
Spending on consumer advertising by drugmakers has increased 62 percent since 2012.
By Bruce Horovitz and Julie Appleby -
Travel Ban Adds Stress To ‘Match Week’ For Some Doctors
Matching with a residency program had an added layer of stress this year for doctors-in-training from the countries affected by President Donald Trump's travel ban.
-
Repeal & Replace Watch
Report: Fired U.S. Attorney Was Probing Tom Price鈥檚 Stock Trades
The HHS Secretary bought stock in companies that stood to benefit from legislation he voted for and sponsored as a Georgia congressman.
By Emily Kopp and Rachel Bluth -
Cholesterol Drug Prevents Heart Attacks 鈥 But It Doesn’t Come Cheap
A cholesterol-lowering drug called Repatha cuts the risk of heart attacks, strokes and heart-related death by 20 percent, according to a new study.
By Liz Szabo -
$89,000 Orphan Drug Gets A New Owner 鈥 And Likely A New Price
Marathon, maker of an expensive treatment for Duchenne muscular dystrophy, sells the drug for $140 million in cash and stock to PTC Therapeutics.
-
Treating Cancer: Hope Vs. Hype
Sticker Shock Forces Thousands Of Cancer Patients To Skip Drugs, Skimp On Treatment
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
By Liz Szabo -
Repeal & Replace Watch
By The Numbers: Trump’s Choice For FDA Chief Is Versatile, Entrenched In Pharma
The numbers show that President Trump鈥檚 choice for FDA commissioner, Scott Gottlieb, has long-standing ties to pharmaceutical companies as a board member or consultant and that he had to recuse himself multiple times while working at the FDA.
-
Two Words Can Soothe Patients Who Have Been Harmed: We鈥檙e Sorry
For patients killed or maimed by medical errors, doctors and hospitals still often deny wrongdoing. But newer programs offering prompt disclosure of medical errors, an apology and compensation for them or their families are growing.
-
Repeal & Replace Watch
Say What? Fact-Checking The Chatter Around The GOP Health Bill
In the heated political arguments as Republicans rush to repeal and replace the Affordable Care Act, some facts can get buried.
By Julie Rovner -
By Law, Hospitals Now Must Tell Medicare Patients When Care Is ‘Observation’ Only
Not being officially admitted 鈥 a status known as observation care 鈥 can have financial consequences for beneficiaries, and patients had often complained they were not informed.
By Susan Jaffe -
HMO Doctors Take Pains To Slash Opioid Prescriptions
A Kaiser Permanente pain management program in Southern California aims to help patients taper off addictive painkillers. Some doctors and patients see it as a godsend; others complain that patients have been cut off medications they need.
By Sam Quinones -
To Save On Drug Costs, Insurer Wants To Steer You To ‘Preferred’ Pharmacies
Blue Shield of California is hoping to steer consumers to "preferred" pharmacies where drugs are cheaper and copays lower.
-
Los Angeles County Scores An E-Success In Managing Specialist Care
An electronic consulting and referral system adopted by the county鈥檚 safety net public health system in 2012 has reduced waiting times for appointments with specialists and eliminated the need for such appointments in a significant number of cases, according to a new study in the journal Health Affairs.
By Anna Gorman